Search

Search Results
Results 6211 - 6220 of 8508 for Skin Cancer
  • Unlocking the secrets of KLK proteases: Bridging cancer research and therapeutic innovation
    Equipment - 21 Mar 2024
    This product profile provides a detailed examination of Kallikrein-related serine proteases (KLKs), emphasizing their critical role in a wide range of physiological and pathological processes.
  • Disrupting the Flow: Dr. Naseri's Revolutionary Approach to Empowering Women's Health
    News - 4 Mar 2024
    An interview with Dr. Sara Naseri, the CEO and Co-Founder of the women’s health company, Qvin.
  • Lozanoc
    Drug - 8 Feb 2024
    Consumer Medicine Information (CMI) about Lozanoc intended for persons living in Australia.
  • Revestive
    Drug - 1 Feb 2024
    Consumer Medicine Information (CMI) about Revestive intended for persons living in Australia.
  • Temodal
    Drug - 29 Jan 2024
    Consumer Medicine Information (CMI) about Temodal intended for persons living in Australia.
  • Nextstellis
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nextstellis intended for persons living in Australia.
  • Emend IV
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Emend IV intended for persons living in Australia.
  • Efudix
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Efudix intended for persons living in Australia.
  • Flosix
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Flosix intended for persons living in Australia.
  • Cinacalcet Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cinacalcet Viatris intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback